Company: NCEL
Filing Date: 2025-09-10
Form Type: 424B3
Source: 0001213900-25-086600
Chunk: 92

Company: NewcelX Ltd.
Filing Date: 2025-09-10
Form: 424B3
Chunk 92
---
 the Kadimastem shares to implement the Merger. •Proposal No. 3 to approve the ordinary share capital increase regarding the issuance of NLS Preferred Shares. •Proposal No. 4 to approve the reinstatement of the capital band. •Proposal No. 5 to approve the conditional share capital for employee and advisory options. •Proposal No. 6 to approve the conditional share capital for shareholders’ options. •Proposal No. 7 to approve the transfer and voting rights limitation of 9.99%. •Proposal No. 8 to approve the name change of NLS. •Proposal No. 9 to approve the election of the new members to the NLS Board. •Proposal No. 10 to approve the election of members of the Compensation, Nomination and Governance Committee. •Proposal No. 11 to approve the composition of the new senior management following the Merger. •Proposal No. 12.1 to approve the compensation for the members of the NLS Board. •Proposal No. 12.2 to approve the compensation for the executive officers. •Proposal No. 13 to approve the CVR Agreement. •Proposal No. 14 to approve the conversion of outstanding options and RSUs issued by Kadimastem. Purpose of the NLS Meeting NLS is holding the NLS Meeting for the following purposes: 1.To approve, on an advisory basis, the Merger Agreement. 2. To approve (i) the reduction of the par value from CHF 0.03 per NLS Common Share, per Preferred Share, and per PPC to (not less than) CHF 0.003 per NLS Common Share, per Preferred Share and per PPC, and book any reduction amount into capital contribution reserves, (ii) the increase of the share capital and the 4 participation capital by such minimum number of NLS Common Shares, Preferred Shares, and PPCs that allows the reverse split under Proposal 2(iii) to take place without fractional Common Shares, Preferred Shares, and PPCs against payment on behalf of the Company of the nominal amount and with exclusion of subscription rights of the shareholders, (iii) the reverse split of the Ordinary Shares, the Preferred Shares, and the PPCs by a reverse split ratio within a range of two -for-one(2:1) to twenty -for-one(20:1), and (iv) the increase of the share capital of the Company, by way of an ordinary capital increase, by up to 3,